Lenumlostat (PAT-1251, GB2064) is a potent, selective, and orally available inhibitor of lysyl oxidase-like 2 (LOXL2). It exhibits greater selectivity for LOXL2 over other family members, with IC50 of 0.71 μM for hLOXL2 and 1.17 μM for hLOXL3. It also possesses anti-fibrotic properties.

EIPA hydrochloride (L593754 hydrochloride, MH 12-43 hydrochloride) is an orally active inhibitor of the TRPP3 channel with an IC50 of 10.5 μM. It also inhibits NHE3, affecting amino acid transport and autophagy regulation in intestinal epithelial cells.

Lenumlostat (PAT-1251, GB2064) is a potent, selective, and orally available inhibitor of lysyl oxidase-like 2 (LOXL2). It exhibits greater selectivity for LOXL2 over other family members, with IC50 of 0.71 μM for hLOXL2 and 1.17 μM for hLOXL3. It also possesses anti-fibrotic properties.

EIPA hydrochloride (L593754 hydrochloride, MH 12-43 hydrochloride) is an orally active inhibitor of the TRPP3 channel with an IC50 of 10.5 μM. It also inhibits NHE3, affecting amino acid transport and autophagy regulation in intestinal epithelial cells.

EIPA hydrochloride (L593754 hydrochloride, MH 12-43 hydrochloride) is an orally active inhibitor of the TRPP3 channel with an IC50 of 10.5 μM. It also inhibits NHE3, affecting amino acid transport and autophagy regulation in intestinal epithelial cells.

EIPA hydrochloride (L593754 hydrochloride, MH 12-43 hydrochloride) is an orally active inhibitor of the TRPP3 channel with an IC50 of 10.5 μM. It also inhibits NHE3, affecting amino acid transport and autophagy regulation in intestinal epithelial cells.

AKT Kinase Inhibitor is an inhibitor of Akt that reverses the protective effects of Tadalafil (TAD) in LPS-induced RWPE-1 cells by decreasing cell viability, promoting apoptosis, and increasing pro-inflammatory cytokine levels.

Clozapine N-oxide dihydrochloride is a primary metabolite of clozapine. It acts as an agonist for human muscarinic designer receptors DREADD, with a pEC50 of 8.31 for the M1 DREADD.

Clozapine N-oxide dihydrochloride is a primary metabolite of clozapine. It acts as an agonist for human muscarinic designer receptors DREADD, with a pEC50 of 8.31 for the M1 DREADD.

Clozapine N-oxide dihydrochloride is a primary metabolite of clozapine. It acts as an agonist for human muscarinic designer receptors DREADD, with a pEC50 of 8.31 for the M1 DREADD.